Tel Aviv-based Sight Diagnostics raised $27.8 million in Series C funding from Longliv Ventures, OurCrowd, Go Capital, and New Alliance Capital, Jack Nicklaus II, Steven Esrick and a major medical equipment manufacturer.
Read more here.
Tel Aviv-based Sight Diagnostics raised $27.8 million in Series C funding from Longliv Ventures, OurCrowd, Go Capital, and New Alliance Capital, Jack Nicklaus II, Steven Esrick and a major medical equipment manufacturer.
Read more here.
![[Juganu in Web Wire] Juganu’s Disinfecting Light Technology Helps Tel Aviv’s Sourasky Medical Center Overcome Hospital-Acquired Infections](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
